Published by If you or a member of your family experienced infection, inflammation, or other serious skin or mucosal complications after using PeriGiene antiseptic cleanser, you may have grounds to pursue financial compensation.
At Schmidt & Clark, we specialize in advocating for consumers harmed by contaminated healthcare and personal hygiene products. Our legal team will work with you to preserve evidence, assess medical impact, and pursue the compensation you deserve. Contact Schmidt & Clark today for a free, no-obligation consultation.
Table Of Contents
What’s the Problem?
The core issue here stems from DermaRite Industries’ voluntary recall of PeriGiene antiseptic cleanser—alongside other products like Dermakleen, Dermasarra, and KleenFoam—due to bacterial contamination with Burkholderia cepacia complex.
This recall includes products intended for intimate or sensitive use, thereby raising concerns about elevated infection risk in areas susceptible to microabrasions and compromised tissue. Although there are no confirmed health incidents reported so far, laboratory testing confirmed contamination in multiple batches, prompting immediate recall.
Recall Timeline & Legal Momentum
- August 8, 2025 – DermaRite announces a voluntary recall on all affected product lines, including PeriGiene [1.]. Consumers are urged to discontinue use immediately.
Scope & Statistics of the Lawsuit
- Affected Product: PeriGiene antiseptic cleanser, along with lotion soaps and cleansers under DermaRite.
- Distribution Extent: Nationwide availability across pharmacies, healthcare facilities, and e-commerce platforms.
- Reported Health Effects: None confirmed to date—but contamination of cleansing products carries inherent heightened risk.
- Legal Status: No lawsuits filed yet; however, intake has begun for potential exposure-related claims.
Public Health Concern & Safety Landscape
PeriGiene was marketed as a trusted antiseptic for perineal hygiene. The possibility of Burkholderia cepacia colonization introduces risk of invasive infection—particularly in users with compromised dermal or mucosal barriers, chronic illness, or existing skin wounds. It undermines essential assumptions about product sterility and safety in sensitive use contexts.
Potential Health Outcomes
Using contaminated PeriGiene may result in a range of adverse outcomes, including:
- Local infections: Dermatitis, Candida overgrowth, or abscesses in perineal or perianal regions.
- Systemic infections: Urinary tract involvement, bacteremia, or even sepsis in vulnerable users.
- Medical complications: Requirement for antibiotics, hospitalization, or surgical intervention in severe cases.
Who May Be Eligible to File?
- You used PeriGiene cleanser included in the recall.
- You developed medically diagnosed infection after using the product.
- Medical evaluation linked your symptoms to possible contamination exposure.
- You have supporting documentation: packaging, purchase receipt, or healthcare records.
- No lawsuit has been filed in your name yet; you’re seeking legal review.
Documents That Strengthen Your Claim
- Proof of product use: receipts, retail records, or photographs.
- Medical documentation: charts, lab results, physician notes linking to product exposure.
- Symptom timeline: onset of issues relative to product use.
- Recall verification: reference materials confirming PeriGiene in recall list.
Recoverable Damages
You may be entitled to compensation for:
- Medical expenses: exam fees, prescription medications, hospitalization.
- Ancillary costs: transport, caregiving, missed work.
- Pain and suffering: emotional impact, physical trauma.
- Punitive damages: if negligence in production or quality control is demonstrated.
Recap: PeriGiene Recall Summary
- Recall Date: August 8, 2025
- Product: PeriGiene antiseptic cleanser (plus adjacent DermaRite soaps and cleansers)
- Hazard: Contamination by Burkholderia cepacia complex
- Distribution: National—pharmacies, hospitals, and online vendors
- Consumer Advisory: Discontinue use immediately; retrieve medical evaluation if symptoms present; retain packaging for possible claim
Legal Deadlines & Action Steps
Product liability and personal injury claims generally must be filed within two to three years of symptom manifestation or discovery of the defect. With the recall issued in August 2025, it’s critical to seek legal counsel promptly to preserve your right to compensation. Certain jurisdictions may offer extended deadlines for cases involving infection or personal injury—consult a lawyer without delay.
Questions Commonly Asked
- How can I start a claim? Contact Schmidt & Clark or a similar product liability law firm to assess your situation and initiate the filing process.
- Who is covered? Consumers who used recalled PeriGiene products and experienced adverse health outcomes.
- Is emotional distress compensable? Yes—cases with serious systemic infection qualify for non-economic damages.
- What should I retain? Product packaging, purchase proof, medical records, and recall information.
- If no symptoms yet? Preserve packaging and obtain a medical evaluation—early documentation helps strengthen future claims.
References
- https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/dermarite-industries-issues-voluntary-nationwide-recall-dermakleen-dermasarra-kleenfoam-and